D G McDevitt, R G Shanks. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AnimalsCatecholamines/adverse effectsClinical Trials as TopicEvaluation Studies as TopicHeart Rate/drug effectsHumansHyperthyroidism/drug therapyOxprenolol/therapeutic usePlacebosPropranolol/therapeutic use
Substances： See more » CatecholaminesPlacebosOxprenololPropranolol
Year: 1973 PMID： 4121565 DOI： 10.1016/s0140-6736(73)91650-4
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321